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Abstract
Background: Air travel has been linked with the development of deep vein thrombosis (DVT)
since the 1950s with a number of plausible explanations put forward for causation. No systematic
review of the literature exploring this association has previously been published.
Methods: A comprehensive search was undertaken (Data bases searched were: MEDLINE,
EMBASE, Cochrane Library) for studies that estimated both the incidence and the risk of DVT in
air travellers relative to non-air travellers.
Results: In total 254 studies were identified but only six incidence studies and four risk studies met
inclusion criteria justifying their use in a systematic review. Incidence of symptomatic DVT ranged
from (0%) in one study to (0.28%) which was reported in pilots over ten years. The incidence of
asymptomatic DVT ranged from (0%) to (10.34%). Pooled odds ratios for the two case control
studies examining the risk of DVT following air travel were 1.11 (95% CI: 0.64–1.94). Pooled odds
ratios for all models of travel including two studies of prolonged air travel (more than three hours)
were 1.70 (95% CI: 0.89–3.22).
Conclusion: We found no definitive evidence that prolonged (more than 3-hours) travel including
air travel, increases the risk of DVT. There is evidence to suggest that flights of eight hours or more
increase the risk of DVT if additional risk factors exist.
Background
The link between air flight and the development of deep
vein thrombosis (DVT) and subsequent pulmonary
embolism (PE) – so called 'thromboembolic disease'- was
first suggested in 1954 by a report describing DVT in a
doctor after a 14-hour flight [1]. Since then there has been
a massive increase in the popularity of air travel. More
than 1.5 billion people travel each year and the Interna-
tional Civil Association Organisation (ICAO) estimates
that this figure will rise to over 2 billion by 2005 [2]. Even
a small increased risk of venous thromboembolic events
(VTE) associated with air travel will cause a substantial
number of VTE. Therefore this topic is a matter of public
health concern. Much has been written in the medical and
popular press about the link between air travel and the
development of deep vein thrombosis (DVT) and pulmo-
nary embolism [3-6]. Not surprisingly this has led to an
increase in reports of what has been called "economy class
syndrome" [7,8] and consequently travellers have been
warned about the thrombosis risk [14].
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to increase the risk of air travellers developing DVT or PE
[9]. These include cramped seating positions, immobility,
possible dehydration due to consumption of alcoholic
drinks and other diuretics such as tea and coffee, and the
low humidity of the aircraft cabin, relative hypoxia and
reduced barometric pressure.
DVT was traditionally diagnosed on clinical grounds (calf
swelling, tenderness and pain). However, researchers
recently using sophisticated techniques have shown that
asymptomatic DVTs can be detected. The prevalence of
asymptomatic deep vein thrombosis in people not sus-
pected of venous thromboembolism on admission to a
medical unit was 5.5% and was 17.8% in people over 80
years old [10]. The need for objective diagnosis of VTE is
illustrated by the following: Less than 50% of patients
with clinically suspected DVT or PE have the diagnosis
confirmed when a routine diagnostic imaging is per-
formed [11,12]. There is limited evidence about the clini-
cal importance of asymptomatic calf vein thrombosis.
Similarly, studies into the incidence of pulmonary embo-
lism associated with isolated calf vein thrombosis
detected asymptomatic embolism by ventilation-per-
fusion scanning, and the clinical relevance of these find-
ings is unclear [13].
About 6% to 20% of the total population is thought to
have some degree of increased clotting tendency. This
indicates that there might be a "natural" underlying inci-
dence of DVT in the general population associated with
those factors [3].
There has been no large-scale cohort study, which has
examined travellers for the development of VTE. The back-
ground incidence of symptomatic DVT in the general pop-
ulation is said to vary between 1:3000 (under the age of
40) and 1:500 (over 80) [3,14]. A recent UK study shows
the annual incidence of symptomatic thrombosis pre-
sented to a hospital in a stable population of 650,000 is
about 1/1000 [15]. Symptomatic DVT is important
because it predisposes to pulmonary embolism, which is
a significant cause of morbidity and mortality [16].
A review of the literature showed no previous systematic
review has examined the evidence for an increase in the
incidence of DVT amongst air travellers.
The World Health Organization (WHO) recently
announced the launch of a comprehensive research pro-
gramme to investigate the unsolved issue of travellers'
thrombosis [17]. However, the study will not be com-
pleted until 2006, subject to funding availability.
This study reviews the literature to estimate the incidence
and the excess risk of DVT in air travellers compared to the
non-travelling population.
Methods
Using a combination of text words and MeSH headings,
MEDLINE, EMBASE, Cochrane databases (CDSR, CEN-
TRAL) and National Research Register (NRR) were
searched using the search strategy shown in Appendix 1
[see Additional file 1]. Citations of included studies and
reviews were checked, and experts in the field were con-
tacted. Two types of studies were sought: incidence rate
from longitudinal studies and comparative studies to esti-
mate the risk of DVT (i.e. the risk of DVT in air travellers
relative to non air travellers). The inclusion criteria are
presented in (Table 1).
Two reviewers (YA, RT) independently extracted data from
the studies and discrepancies were resolved by discussion.
A distinction was made between studies reporting symp-
tomatic DVT and those reporting asymptomatic DVT.
Results from the risk studies were pooled using standard
Summary of the included studiesFigure 1
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Meta-analysis was carried out using Stata™ 7.0 [18].
Results
254 studies were identified by our searches. Six incidence
studies and four risk studies met the inclusion criteria of
the review (Figure 1).
Incidence of symptomatic DVT in air travel
Two studies reported the incidence of symptomatic DVT
in air travel (Table 2).
Johnson and Evans [19] observed 27 cases of DVT over 10
years in 9,775 pilots, the 10 years incidence was 0.28%.
Arfvidsson [20] reported no symptomatic DVTs in 83
individuals, in the 4 weeks following flying (5 hours or
more) to and from a medical conference in Hawaii.
Incidence of asymptomatic DVT in air travel
The remaining four studies, Lonflit I (1.4%) [21], Sesa-
rone (4.0%) [22], Lonflit II (4.50%) [21], Scurr (10.34%)
[23] reported much higher incidences of DVT following
prolonged flights (Table 2). However, in all the remaining
four studies, the DVTs reported were asymptomatic condi-
tions, which were detected by using diagnostic methods.
Table 1: Inclusion criteria
Incidence of DVT during air flight
Design Any design other than case report
Population Any individuals who have travelled by air regardless of sex, age or risk status
Exposure Air travel (short or prolonged flight)
Comparator Not required
Outcomes Asymptomatic or symptomatic VTE confirmed by clinical or diagnostic methods, or related mortality
Air flight as a risk factor for DVT
Design Any comparative study design i.e. randomised controlled trial, prospective or retrospective cohort study or 
case control study.
Population Any individuals who have travelled by air regardless of sex, age or risk status.
Exposure Air travel (short or prolonged flight)
Comparator No air travel
Outcomes Asymptomatic or symptomatic VTE confirmed by clinical or diagnostic methods, pulmonary embolus (PE) or 
related mortality up to month after exposure
Table 2: Incidence studies
Study 
Characteristics
Johnston & Evans 
(2001) [19]
Arfvidsson 
(2001) [20]
Scurr (2001) 
[23]
Cesarone (2002) 
LONFLIT 3 [22]
Belcaro (2001) 
LONFLIT I [21]
Belcaro (2001) 
LONFLIT II [21]
Population Healthy workers – 
pilots
Otherwise 
healthy- 
conference 
attendants
No history of 
VTE- apparently 
healthy individuals
High risk group Both low and high 
risk
High risk subjects
Definition of VTE NOT Stated (but it 
likely to be 
symptomatic)
DVT symptomatic DVT 
asymptomatic
DVT asymptomatic DVT 
asymptomatic
DVT 
asymptomatic
Method of 
diagnosis
Undefined Diagnostic test Diagnostic tests Diagnostic test Diagnostic test Diagnostic test
Nature of 
exposure
Population of pilots ≥ 5 hours flight ≥ 8 hours flight Not stated Average 12.4 
hours flight
Average 12.5 
hours
Reported rate of 
VTE n/N
27/9775 (0.28%) 
during 10 years 
study
0/83 (0%) 12/116 (10.34%) 4/100 (4.00%) 11/778 (1.41%) 19/422 (4.50%)
Period of follow 
up
Person-year data is 
not stated. 10 years 
study, but little 
details given about 
the follow up.
4 weeks Up to 6 weeks Not stated 
Immediately post 
flight?
24 hours 24 hoursPage 3 of 8
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Two case control studies examined the excess risk of devel-
oping DVT in air travellers relative to non-air travellers
(Table 3). Kraaijenhagen [24] identified 788 individuals
presenting to an outpatient department with suspected
DVT cases of which (186) cases were defined as those who
were confirmed by diagnostic tests (compression ultra-
sonography and D-dimer) and those not confirmed, taken
as controls (602). Individuals were questioned about tak-
ing a flight of more than 3 hours in the preceding 4 weeks.
Using a similar design, Arya et al [25] identified 568 con-
secutive patients with suspected DVT attending hospital,
185 cases of confirmed DVTs (by duplex ultrasonogra-
phy) and 383 unconfirmed controls.
Pooling these two studies revealed no evidence of an
increase in the risk of DVT with prolonged air travel (odds
ratio: 1.11, 95% CI: 0.64 to 1.94) (Figure 2).
Risk of symptomatic DVT in travellers (regardless of travel 
modes)
Two case control studies reported the excess risk of DVT
associated with all forms of prolonged travel (Table 3).
Ferrari [26] assessed 160 patients hospitalised in a cardi-
ology department, presenting with DVT or PE. All jour-
neys (by car, train, sea or air) lasting 4 hours, or more, in
the preceding 4 weeks were sought. The same questions
were put to an age-matched control group of consecutive
patients admitted to the department during the same
period, without DVT or PE. Nine (6%) patients with DVT
had travelled by air. The odds ratio was not reported for
this group.
Samama [27] investigated 494 cases of confirmed DVT
reported, and 494 age and sex matched controls (individ-
uals with influenza or rhinopharyngeal syndrome) identi-
fied by GPs. Individuals were questioned about long
distance travel within the previous 3 weeks.
Table 3: Main study characteristics of the comparative risk of DVT
Study 
Characteristics
Ferrari et al (1999) 
[26] France
Kraaijenhagen et al (2000) 
[24] The Netherlands
Samama (2000) [27] France Ayra (2002) [25] United 
Kingdom
Total sample size N = 320 N = 788 N = 988 N = 568
Mean age (SD) 66 (16) yrs 61 (17.2) yrs 59.1 yrs (17.3) cases, 58.1 yrs 
(16.8) in control group
54 yrs
Male (%) 188 (59%) 313 (40%) 454 (36%) 202 (36%)
Sources of cases Consecutive patients 
hospitalised for DVT or 
PE
Consecutive individuals 
presenting to outpatients with 
confirmed DVT
Confirmed cases of DVT identified 
through general practices
Consecutive individuals 
with confirmed DVT 
presenting to an A&E Dept 
or primary care
Sources of 
control
No DVT or PE age-
matched
Individuals where DVT were not 
confirmed Age & sex matched
No DVT (494) Age/sex matched Individuals where DVT not 
confirmed
Case definition Ultrasound echo-
Doppler examination)
Compression ultrasonography, 
D-dimer assay and clinical follow 
ups and venography, ventilation 
perfusion lung scan or 
angiogram)
Venography, duplex 
ultrasonography, B mode 
untrasonography, and /or 
impedance plethysmography
Duplex ultrasonography
Exposure Any travel > 4 hrs in last 
4 weeks (self report)
Air travel > 3 hrs in last 4 weeks 
(Patient self report)
Any travel > 6 hrs in last 3 weeks 
(Patient self report – case notes)
Air travel > 3 hrs* in last 4 
weeks (Patient self report)
Comments Of those cases with 
DVT only 9 out of 39 
patients travel by air.
The control group may 
be less likely to travel 
by air due to lower 
social class compared 
with cases.
If control individuals 
were ill in the last three 
weeks, they are less 
likely to have travelled 
compared with cases.
Many flew less than 5 hours.
People included in the study 
(cases or control) have several 
potential confounding factor they 
are not apparently healthy before 
the travel.
There are limited numbers of 
patients with DVT who travel by 
air in cases (4) and control, (13).
The number of continuous hours 
that was investigated was more 
than 3 hours, a period seems 
shorter than other studies.
Participants were asked about 
travel history before they knew 
the results of objective diagnosis 
to avoid referral bias.
Included patients in cases were 
individuals with surgery and 
plaster cast in previous 3 weeks flu 
or rhinopharygeal syndrome 
matched on sex and age +/- 10 
years.
Long -distance travel and not 
specifically air travel that was 
addressed as risk factor for DVT. 
The length of travel was not 
specified.
If control individuals were ill in the 
last three weeks, they are less 
likely to have travelled compared 
with cases in the last 3 weeks.
The distribution of intrinsic and 
triggering risk factors are different 
between case and control patients.
>8 hrs of air travel was not 
reported as a significant 
factor.
The risk factor in relation 
to travel is only apparent if 
there was at least one risk 
factorPage 4 of 8
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dence of a small but non-statistically significant increase
in the risk of symptomatic DVT (odds ratio: 1.70, 95% CI:
0.89 to 3.22) associated with all forms of prolonged travel
(Figure 3).
Discussion
We found no evidence to support the claim that air travel
(3 hours or more) is associated with an increased risk of
developing DVT. We identified a wide range of estimates
of the incidence of DVT in air travellers. Symptomatic
DVT despite its prominence in the press is remarkably
rare. Many published studies related to asymptomatic
DVT, the clinical significance of which remains uncertain
and needs to be ascertained. Interestingly, there was evi-
dence of a small increase in the risk of symptomatic DVTs
associated with all forms of long distance travel. This find-
ing is suggestive that travel by land puts individuals at
more risk of DVT than air travel.
With regard to passengers in Kraaijenhagen et al study
[24], patients who travel more than 5 hours, no associated
risk of DVT was shown. We believe that this finding from
the analysis of this subgroup cannot be confidently inter-
preted. This is because the total number of patients with
DVT who travel by plane was reported as 4/186 and in the
control (without DVT) 13/602. Any subgroup analysis
according to the length of flight e.g. 10 hours would fur-
ther reduce the number of cases and consequently would
reduce the power of the study.
In Arya et al study [25], plane travel >than 8 hours in
patients with 568 suspected venous thrombosis was not
associated with a statistically increased risk, (OR:1.3, 95%
CI :0.6 to 2.8) However this study reported plane travel >8
hours with one or more additional risk factors would sig-
nificantly increase the risk, (OR: 3.0, 95% CI:1.1 to 8.2).
There are certain factors that make establishing an associ-
ation rather difficult. These are: the low rate of back-
Risk of symptomatic DVT with air travel>3 hoursF gure 2
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the low exposure to flying in the individual level and the
short duration of exposure.
Given the limited amount of evidence available, this
review has insufficient power to confirm a statistically sig-
nificant increase in risk of DVT associated with air travel,
if such a risk exists. It is therefore tempting to suggest that
we should await the publication of data before we can
establish the relationship between air travel and DVT. The
likely estimates of incidence and increased risk are such
that the required sample size may be unobtainable. Based
on the plausible range of increased risk observed in this
review (i.e. odds ratio of 1.10 to 1.94), follow up of about
a million air travellers (plus control) would be required to
confidently confirm an increased risk. We cannot imagine
that such a large study will ever be performed (Table 4).
The total number of individuals in this review was n =
1025 with a history of travel and n = 1639 of those with-
out a history of recent travel. Therefore the combined
studies are grossly under powered to detect any reasona-
ble increased risk associated with air travel. Table 4 shows
Risk of DVT associated with all modes of travel (i.e. air, care, bus, and rail)F gure 3
Risk of DVT associated with all modes of travel (i.e. air, care, bus, and rail)
Table 4: The sample size needed to show the risk of DVT in relation to air travel
Background 
annual 
incident rate
Background 
Weekly 
incidence rate
Assuming Odds 
Ratio associated 
with travelling is
Number of 
air travellers 
needed/ week
Number of non 
air travellers/ 
week
Events of 
exposed/ 
week
Events of 
unexposed
/ week
Extra 
events in 
exposed/ 
week
Total 
events/ 
week
1/1,000 2/100,000 2 1,275,418 1,275,418 52 26 26 78
1/1,000 2/100,000 3 392,463 392,463 24 8 16 32Page 6 of 8
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80% power and 5% significance. Background weekly inci-
dence was stated to reflect the fact that any added risk
from travel would occur within a week of travel. It is
assumed also that there is no more than one episode of
travel /week (Table 4).
If flight longer than 8 hours were associated with a very
high risk of DVT (e.g. Odds ratio 4) sample size studies
suggest that 4,400 passengers (plus suitable controls)
would be needed. Due to problems with matching, follow
up etc, this number should probably be increased up to
ten fold (44,000 passengers) [28].
It would be convenient to limit any future case control
studies to very long flights, and in people who travel very
frequently. The justification for this suggestion is that if
such frequent travellers show no increased risk, then it is
very unlikely that infrequent air travellers or those who
travel only for a short flight would be at an increased risk.
Conclusions
We conclude that there is currently no definitive evidence
that air travel increases the risk of DVT. However, there is
some evidence to suggest that flights of eight hours or
more increase the risk of DVT if additional risk factors
exist. Moreover, given the low incidence of DVT in the
general population we may never know if air travel
increases the risk of DVT because studies with the required
sample size to detect a significantly increased risk are
unlikely to be sponsored.
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